Floatz logo

Soquelitinib

Nodal T-Follicular Helper Cell Lymphoma, Follicular Type

Corvus Pharmaceuticals, Inc.Small moleculePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
89/ 100

Competitive context

15 Active assets in the Nodal T-Follicular Helper Cell Lymphoma, Follicular Type cohort.

Asset / SponsorPhaseRating
Pralatrexate
Corvus Pharmaceuticals, Inc.
Phase 3BB
Pembrolizumab
Northwestern University
Phase 2B
FILGRASTIM
City of Hope Medical Center
Phase 3B
Belinostat
Corvus Pharmaceuticals, Inc.
Phase 3B
Cyclophosphamide
City of Hope Medical Center
Phase 2B

View all 18 →

Same molecule, other indications

Soquelitinib is also rated in:

T-cell non-Hodgkin lymphomaDormant
B
Indicative ·
62 / 100
View asset →
peripheral T-cell lymphoma, not otherwise specifiedDormant
B
Indicative ·
60 / 100
View asset →
ALK-positive anaplastic large cell lymphomaDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →